These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 18036397)
21. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo? Nagao M; Nakajima Y; Hisanaga M; Kayagaki N; Kanehiro H; Aomatsu Y; Ko S; Yagita H; Yamada T; Okumura K; Nakano H Hepatology; 1999 Aug; 30(2):413-21. PubMed ID: 10421649 [TBL] [Abstract][Full Text] [Related]
22. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha. Qin HY; Chaturvedi P; Singh B Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021 [TBL] [Abstract][Full Text] [Related]
23. FasL/Fas pathway is involved in dengue virus induced apoptosis of the vascular endothelial cells. Liao H; Xu J; Huang J J Med Virol; 2010 Aug; 82(8):1392-9. PubMed ID: 20572077 [TBL] [Abstract][Full Text] [Related]
24. Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells. Hedlund TE; Meech SJ; Srikanth S; Kraft AS; Miller GJ; Schaack JB; Duke RC Cell Death Differ; 1999 Feb; 6(2):175-82. PubMed ID: 10200564 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism. Schneider-Brachert W; Tchikov V; Merkel O; Jakob M; Hallas C; Kruse ML; Groitl P; Lehn A; Hildt E; Held-Feindt J; Dobner T; Kabelitz D; Krönke M; Schütze S J Clin Invest; 2006 Nov; 116(11):2901-13. PubMed ID: 17024246 [TBL] [Abstract][Full Text] [Related]
26. Fas-Fas ligand signaling pathway mediates an interleukin-12-induced rejection of a murine prostate tumor system. Zhang S; Zeng G; Kao C; Gardner T; Sweeney C; Yang NS; Eble JN; Cheng L Prostate; 2002 Sep; 53(1):69-76. PubMed ID: 12210482 [TBL] [Abstract][Full Text] [Related]
27. Antitumor effects are produced by forced expression of membrane-bound but not soluble Fas ligand in murine lung carcinoma cells. Tada Y; O-Wang J; Seimiya M; Takiguchi Y; Tatsumi K; Kuriyama T; Tagawa M Anticancer Res; 2002; 22(2A):831-6. PubMed ID: 12014659 [TBL] [Abstract][Full Text] [Related]
28. Attack the tumor counterattack-c-FLIP expression in Jurkat-T-cells protects against apoptosis induced by coculture with SW620 colorectal adenocarcinoma cells. Steiert AE; Sendler D; Burke WF; Choi CY; Reimers K; Vogt PM J Surg Res; 2012 Jul; 176(1):133-40. PubMed ID: 21944480 [TBL] [Abstract][Full Text] [Related]
29. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development. Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253 [TBL] [Abstract][Full Text] [Related]
30. Correlation between expression of DcR3 on tumor cells and sensitivity to FasL. Li W; Zhang C; Chen C; Zhuang G Cell Mol Immunol; 2007 Dec; 4(6):455-60. PubMed ID: 18163957 [TBL] [Abstract][Full Text] [Related]
31. Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand. Kim H; Rhee SH; Pothoulakis C; Lamont JT Gastroenterology; 2007 Sep; 133(3):875-86. PubMed ID: 17854595 [TBL] [Abstract][Full Text] [Related]
32. Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression. Hyer ML; Sudarshan S; Schwartz DA; Hannun Y; Dong JY; Norris JS Cancer Gene Ther; 2003 Apr; 10(4):330-9. PubMed ID: 12679806 [TBL] [Abstract][Full Text] [Related]
33. Human colon cancer cells express the functional Fas ligand. Ding EX; Hizuta A; Morimoto Y; Tanida T; Hongo T; Ishii T; Yamano T; Fujiwara T; Iwagaki H; Tanaka N Res Commun Mol Pathol Pharmacol; 1998 Jul; 101(1):13-24. PubMed ID: 9755840 [TBL] [Abstract][Full Text] [Related]
34. [p53-dependent antiproliferation and apoptosis of H22 cell induced by melatonin]. She MH; Chen BB; Wang XM; He SS Ai Zheng; 2004 Jul; 23(7):803-7. PubMed ID: 15248916 [TBL] [Abstract][Full Text] [Related]
35. Direct in vivo transfection of antisense Fas-ligand reduces tumor growth and invasion. Nyhus JK; Wolford C; Feng L; Barbera-Guillem E Gene Ther; 2001 Feb; 8(3):209-14. PubMed ID: 11313792 [TBL] [Abstract][Full Text] [Related]
36. Activated T cell exosomes promote tumor invasion via Fas signaling pathway. Cai Z; Yang F; Yu L; Yu Z; Jiang L; Wang Q; Yang Y; Wang L; Cao X; Wang J J Immunol; 2012 Jun; 188(12):5954-61. PubMed ID: 22573809 [TBL] [Abstract][Full Text] [Related]
37. Secondary apoptosis of spiral ganglion cells induced by aminoglycoside: Fas-Fas ligand signaling pathway. Bae WY; Kim LS; Hur DY; Jeong SW; Kim JR Laryngoscope; 2008 Sep; 118(9):1659-68. PubMed ID: 18758324 [TBL] [Abstract][Full Text] [Related]
38. Overexpression of Fas ligand does not confer immune privilege to a pancreatic beta tumor cell line (betaTC-3). Okamoto S; Takamizawa S; Bishop W; Wen J; Kimura K; Sandler A J Surg Res; 1999 Jun; 84(1):77-81. PubMed ID: 10334893 [TBL] [Abstract][Full Text] [Related]
39. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis. Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415 [TBL] [Abstract][Full Text] [Related]
40. Gene transduction of tristetraprolin or its active domain reduces TNF-alpha production by Jurkat T cells. Suzuki E; Tsutsumi A; Goto D; Matsumoto I; Ito S; Otsu M; Onodera M; Takahashi S; Sato Y; Sumida T Int J Mol Med; 2006 May; 17(5):801-9. PubMed ID: 16596264 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]